2927 — AFC-HD AMS Life Science Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeSmall CapNeutral

Annual income statement for AFC-HD AMS Life Science Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

	2021 August 31st	C2022 August 31st	2023 August 31st	2024 August 31st	2025 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,368	23,025	25,579	30,185	32,655
Cost of Revenue
Gross Profit	6,865	8,583	9,323	10,492	11,261
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	20,126	22,118	24,051	28,317	30,486
Operating Profit	2,242	907	1,528	1,868	2,169
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,158	1,235	1,546	1,911	2,201
Provision for Income Taxes
Net Income After Taxes	1,495	738	1,107	1,245	1,469
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,496	735	1,103	1,252	1,449
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	1,496	735	1,103	1,252	1,449
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	109	67.5	95.4	105	135
Dividends per Share